{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:06Z","timestamp":1747207326900,"version":"3.40.5"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2021,2,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Several compounds have been synthesized as a therapeutic alternative for\nheart failure; however, its preparation requires special conditions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this study, was to synthesize some aniline derivatives (4-9) from 3-\nethynylaniline to evaluate their biological activity against heart failure.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The synthesis of aniline derivatives involved a series of reactions such as etherification,\naddition, and cyclization. The structure of all compounds obtained was confirmed by spectroscopic\nand spectrometric methods. In addition, to evaluate the biological activity of compounds, an\nischemia\/reperfusion injury model was used.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results showed that compound 8 decreases heart failure, which translates into a\ndecrease in the infarction area compared to compounds 4-7 and 9.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study reports a facile method for the preparation of aniline derivatives. This method\noffers some advantages such as; a simple procedure, low cost, and easy work up. In addition,\ncompound 8 showed an interesting biological activity against heart failure. This phenomenon is\nparticularly interesting because the biological activity induced by this compound could involve a\nmolecular mechanism that is different from other drugs used for the treatment of heart failure.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207323666200709163008","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T09:20:09Z","timestamp":1594372809000},"page":"220-232","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design and Synthesis of an Aniline Derivative with Biological Activity on Heart Failure"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-7804","authenticated-orcid":true,"given":"Garcimarero-Espino E.","family":"Alejandra","sequence":"first","affiliation":[{"name":"Facultad de Medicina, Universidad Veracruzana. M\u00e9dicos y Odont\u00f3logos s\/n, 91010, Xalapa, Veracruz, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figueroa-Valverde","family":"Lauro","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaco-Chemistry at the Faculty of Chemical Biological Sciences of the University Autonomous of Campeche, Av. Ex Hacienda Kala s\/n, 24085 San Francisco de Campeche, Campeche, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7119-4728","authenticated-orcid":true,"given":"Rosas-Nexticapa","family":"Marcela","sequence":"additional","affiliation":[{"name":"Facultad de Nutricion, Universidad Veracruzana. Medicos y Odontologos s\/n, 91010, Xalapa, Veracruz, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-0549","authenticated-orcid":true,"given":"Lopez-Ramos","family":"Maria","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaco-Chemistry at the Faculty of Chemical Biological Sciences of the University Autonomous of Campeche, Av. Ex Hacienda Kala s\/n, 24085 San Francisco de Campeche, Campeche, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4613-9836","authenticated-orcid":true,"given":"Diaz Cedillo","family":"Francisco","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biologicas del Instituto Politecnico Nacional. Prol. Carpio y Plan de Ayala s\/n Col. Santo Tomas, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateu-Armand","family":"Virginia","sequence":"additional","affiliation":[{"name":"Facultad de Nutricion, Universidad Veracruzana. Medicos y Odontologos s\/n, 91010, Xalapa, Veracruz, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3935-0142","authenticated-orcid":true,"given":"Ortiz-Ake","family":"Yazmin","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaco-Chemistry at the Faculty of Chemical Biological Sciences of the University Autonomous of Campeche, Av. Ex Hacienda Kala s\/n, 24085 San Francisco de Campeche, Campeche, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006472","volume":"13","author":"Lawson C.A.","year":"2020","unstructured":"Lawson C.A.; Zaccardi F.; Squire I.; Okhai H.; Davies M.; Huang W.; Mamas M.; Lam C.S.P.; Khunti K.; Kadam U.T.; Risk factors for heart failure: 20-year population-based trends by sex, socioeconomic status, and ethnicity. Circ Heart Fail 2020,13(2)","journal-title":"Circ Heart Fail"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012884","volume":"8","author":"Yu Y.","year":"2019","unstructured":"Yu Y.; Gupta A.; Wu C.; Masoudi F.A.; Du X.; Zhang J.; Krumholz H.M.; Li J.; China PEACE Collaborative Group. Characteristics, management, and outcomes of patients hospitalized for heart failure in China: The China PEACE retrospective heart failure study. J Am Heart Assoc 2019,8(17)","journal-title":"J Am Heart Assoc"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1161\/STROKEAHA.117.016926","volume":"48","author":"Kim T.H.","year":"2017","unstructured":"Kim T.H.; Yang P.S.; Uhm J.S.; Kim J.Y.; Pak H.N.; Lee M.H.; Joung B.; Lip G.Y.H.; CHA2DS2-VASc score (congestive heart failure, hypertension, age\u2265 75 [doubled], diabetes mellitus, prior stroke or transient ischemic attack [doubled], vascular disease, age 65\u201374, female) for stroke in Asian patients with atrial fibrillation: a Korean nationwide sample cohort study. Stroke 2017,48(6),1524-1530","journal-title":"Stroke"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","volume":"380","author":"Velazquez E.J.","year":"2019","unstructured":"Velazquez E.J.; Morrow D.A.; DeVore A.D.; Duffy C.I.; Ambrosy A.P.; McCague K.; Rocha R.; Braunwald E.; PIONEER-HF Investigators Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med 2019,380(6),539-548","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa020245","volume":"347","author":"Kenchaiah S.","year":"2002","unstructured":"Kenchaiah S.; Evans J.C.; Levy D.; Wilson P.W.; Benjamin E.J.; Larson M.G.; Kannel W.B.; Vasan R.S.; Obesity and the risk of heart failure. N Engl J Med 2002,347(5),305-313","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"Dunlay S.M.","year":"2019","unstructured":"Dunlay S.M.; Givertz M.M.; Aguilar D.; Allen L.A.; Chan M.; Desai A.S.; Deswal A.; Dickson V.V.; Kosiborod M.N.; Lekavich C.L.; McCoy R.G.; Mentz R.J.; Pi\u00f1a I.L.; American heart association heart failure and transplantation committee of the council on clinical cardiology; council on cardiovascular and stroke nursing; and the heart failure society of america. Type 2 diabetes mellitus and heart failure: A scientific statement from the american heart association and the heart failure society of america: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation 2019,140(7),e294-e324","journal-title":"Circulation"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","volume":"139","author":"Morrow D.A.","year":"2019","unstructured":"Morrow D.A.; Velazquez E.J.; DeVore A.D.; Desai A.S.; Duffy C.I.; Ambrosy A.P.; Gurmu Y.; McCague K.; Rocha R.; Braunwald E.; Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril\/valsartan or enalapril in the PIONEER-HF Trial. Circulation 2019,139(19),2285-2288","journal-title":"Circulation"},{"key":"ref=8","first-page":"S28","volume":"3","author":"Emerman C.L.","year":"2002","unstructured":"Emerman C.L.; Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Rev Cardiovasc Med 2002,3(Suppl. 4),S28-S34","journal-title":"Rev Cardiovasc Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jama.1988.03720040031022","volume":"259","year":"1988","unstructured":"The Captopril-Digoxin Multicenter Research Group Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988,259(4),539-544","journal-title":"JAMA"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"Pitt B.","year":"2014","unstructured":"Pitt B.; Pfeffer M.A.; Assmann S.F.; Boineau R.; Anand I.S.; Claggett B.; Clausell N.; Desai A.S.; Diaz R.; Fleg J.L.; Gordeev I.; Harty B.; Heitner J.F.; Kenwood C.T.; Lewis E.F.; O\u2019Meara E.; Probstfield J.L.; Shaburishvili T.; Shah S.J.; Solomon S.D.; Sweitzer N.K.; Yang S.; McKinlay S.M.; TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014,370(15),1383-1392","journal-title":"N Engl J Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"47G","DOI":"10.1016\/j.amjcard.2005.07.021","volume":"96","author":"Bayram M.","year":"2005","unstructured":"Bayram M.; De Luca L.; Massie M.B.; Gheorghiade M.; Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005,96(6A),47G-58G","journal-title":"Am J Cardiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/cpt1978245537","volume":"24","author":"Kates R.E.","year":"1978","unstructured":"Kates R.E.; Leier C.V.; Dobutamine pharmacokinetics in severe heart failure. Clin Pharmacol Ther 1978,24(5),537-541","journal-title":"Clin Pharmacol Ther"},{"key":"ref=13","first-page":"66","volume":"3","author":"Zairis M.","year":"2004","unstructured":"Zairis M.; Apostolatos C.; Anastassiadis F.; Kouris N.; Grassos H.; Sifaki M.; Comparison of the effect of levosimendan, or dobutamin or placebo in chronic low output decompensated heart failure. CAlcium sensitizer or Inotrope or NOne in low output heart failure (CASINO) study. Eur J Heart Fail 2004,3,66-66","journal-title":"Eur J Heart Fail"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0002-8703(96)90365-8","volume":"131","author":"Kostis J.B.","year":"1996","unstructured":"Kostis J.B.; Shelton B.; Gosselin G.; Goulet C.; Hood W.B.; Kohn R.M.; Kubo S.H.; Schron E.; Weiss M.B.; Willis P.W.; Young J.B.; Probstfield J.; SOLVD Investigators Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J 1996,131(2),350-355","journal-title":"Am Heart J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"Cuffe M.S.","year":"2002","unstructured":"Cuffe M.S.; Califf R.M.; Adams K.F.; Benza R.; Bourge R.; Colucci W.S.; Massie B.M.; O\u2019Connor C.M.; Pina I.; Quigg R.; Silver M.A.; Gheorghiade M.;  Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA, 2002,287(12),1541-1547","journal-title":"Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA,"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jama.1973.03220280028007","volume":"225","author":"Greenblatt D.J.","year":"1973","unstructured":"Greenblatt D.J.; Koch-Weser J.; Adverse reactions to spironolactone: a report from the Boston Collaborative Drug Surveillance Program. JAMA 1973,225(1),40-43","journal-title":"JAMA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1021\/jm0503704","volume":"48","author":"Voets M.","year":"2005","unstructured":"Voets M.; Antes I.; Scherer C.; M\u00fcller-Vieira U.; Biemel K.; Barassin C.; Marchais-Oberwinkler S.; Hartmann R.W.; Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis. J Med Chem 2005,48(21),6632-6642","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/acsmedchemlett.6b00122","volume":"7","author":"Tang H.","year":"2016","unstructured":"Tang H.; Zhu Y.; Teumelsan N.; Walsh S.; Shahripour A.; Priest B.; Thomas-Fowlkes B.; Discovery of BMS-955176, a second generation HIV-1 maturation inhibitor with broad spectrum antiviral activity. Med Chem Lett 2016,7,697-701","journal-title":"Med Chem Lett"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/jo00001a084","volume":"56","author":"Corey E.","year":"1991","unstructured":"Corey E.; Link J.; A catalytic enantioselective synthesis of denopamine, a useful drug for congestive heart failure. J Org Chem 1991,56,442-444","journal-title":"J Org Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.1016\/j.bmcl.2012.05.019","volume":"22","author":"Ravinder M.","year":"2012","unstructured":"Ravinder M.; Mahendar B.; Mattapally S.; Hamsini K.V.; Reddy T.N.; Rohit C.; Srinivas K.; Banerjee S.K.; Rao V.J.; Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation. Bioorg Med Chem Lett 2012,22(18),6010-6015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","first-page":"1703","volume":"5","author":"Figueroa L.","year":"2011","unstructured":"Figueroa L.; D\u00edaz F.; L\u00f3pez M.; Garc\u00eda E.; Pool E.; Design and synthesis of an estradiol derivative and evaluation of its inotropic activity in isolated rat heart. Afr J Pharm Pharmacol 2011,5,1703-1712","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref=22","first-page":"3543","author":"Figueroa-Valverde L.","year":"2018","unstructured":"Figueroa-Valverde L.; D\u00edaz-Cedillo F.; Rosas-Nexticapa M.; Mateu V; Garcia-Cervera E.; L\u00f3pez-Ramos M.;  Activation of estrogen receptor-\u03b1 protects the in vivo rabbit heart from ischemia-reperfusion injury BiointerBiointer Res Appl Chem, 2018,3543-3551","journal-title":"Activation of estrogen receptor-\u03b1 protects the in vivo rabbit heart from ischemia-reperfusion injury BiointerBiointer Res Appl Chem,"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"H2039","DOI":"10.1152\/ajpheart.00479.2005","volume":"289","author":"Booth E.A.","year":"2005","unstructured":"Booth E.A.; Obeid N.R.; Lucchesi B.R.; Activation of estrogen receptor-\u03b1 protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2005,289(5),H2039-H2047","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=24","first-page":"769","volume":"67","author":"Hocht C.","year":"1999","unstructured":"Hocht C.; Opezzo J.; Gorzalczany S.; Una aproximaci\u00f3n cin\u00e9tica y din\u00e1mica de metildopa en ratas con coartaci\u00f3n a\u00f3rtica mediante microdi\u00e1lisis. Rev Argent Cardiol 1999,67,769-773","journal-title":"Rev Argent Cardiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1021\/acs.orglett.7b01847","volume":"19","author":"Nishimoto Y.","year":"2017","unstructured":"Nishimoto Y.; Kang K.; Yasuda M.; Regio- and Stereoselective Anti-Carbozincation of Alkynyl Ethers Using ZnBr2 toward (Z)-\u03b2-Zincated Enol Ether Synthesis. Org Lett 2017,19(14),3927-3930","journal-title":"Org Lett"},{"key":"ref=26","first-page":"8879","volume":"21","author":"Chen X.","year":"2019","unstructured":"Chen X.; Xiao X.; Sun H.; Li Y.; Cao H.; Zhang X.; Lian Z.; Transition-metal-catalyzed transformation of sulfonates via S\u2013O bond cleavagE: Synthesis of Alkyl Aryl Ether and Diaryl Ether. Org.anic Lett., 2019,21(22),8879-8883"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1021\/ol4010189","volume":"15","author":"Kuriyama M.","year":"2013","unstructured":"Kuriyama M.; Matsuo S.; Shinozawa M.; Onomura O.; Ether-imidazolium carbenes for Suzuki-Miyaura cross-coupling of heteroaryl chlorides with aryl\/heteroarylboron reagents. Org Lett 2013,15(11),2716-2719","journal-title":"Org Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1021\/ol048485+","volume":"6","author":"Nakajima M.","year":"2004","unstructured":"Nakajima M.; Orito Y.; Ishizuka T.; Hashimoto S.; Enantioselective aldol reaction of trimethoxysilyl enol ether catalyzed by lithium binaphtholate. Org Lett 2004,6(21),3763-3765","journal-title":"Org Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00769498","volume":"18","author":"Fu Z.","year":"1993","unstructured":"Fu Z.; Ono Y.; Selective N-monomethylation of aniline with dimethyl carbonate over Y-zeolites. Catal Lett 1993,18,59-63","journal-title":"Catal Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0926-860X(99)00031-9","volume":"182","author":"Sreekumar K.","year":"1999","unstructured":"Sreekumar K.; Raja T.; Kiran B.; Sugunan S.; Rao B.; Selective N-monomethylation of aniline over Zn1\u2212 xNixFe2O4 (x= 0, 0.2, 0.5, 0.8 and 1) type systems. Appl Catal 1999,182,327-336","journal-title":"Appl Catal"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"11744","DOI":"10.1021\/acssuschemeng.7b03246","volume":"5","author":"Chen J.","year":"2017","unstructured":"Chen J.; Wu J.; Tu T.; Sustainable and selective monomethylation of anilines by methanol with solid molecular NHC-Ir catalysts. ACS Sustain Chem 2017,5,11744-11751","journal-title":"ACS Sustain Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1039\/C7CC02314F","volume":"53","author":"Wang H.","year":"2017","unstructured":"Wang H.; Huang Y.; Dai X.; Shi F.; N-Monomethylation of amines using paraformaldehyde and H2. Chem Commun (Camb) 2017,53(40),5542-5545","journal-title":"Chem Commun (Camb)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1021\/acs.orglett.8b01449","volume":"20","author":"Ogata O.","year":"2018","unstructured":"Ogata O.; Nara H.; Fujiwhara M.; Matsumura K.; Kayaki Y.; N-monomethylation of aromatic amines with methanol via PNHP-pincer Ru catalysts. Org Lett 2018,20(13),3866-3870","journal-title":"Org Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/cctc.201100185","volume":"3","author":"Motokura K.","year":"2011","unstructured":"Motokura K.; Nakayama K.; Miyaji A.; Baba T.; \u201cLigand\u2010Consuming\u201d Formation of rhodium\u2010hydride species from [Rh (OH)(cod)] 2 without any additional hydride sources for catalytic olefin isomerizations and cyclobutene synthesis. ChemCatChem 2011,3,1419-1421","journal-title":"ChemCatChem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.1002\/anie.200803910","volume":"47","author":"Xu H.","year":"2008","unstructured":"Xu H.; Zhang W.; Shu D.; Werness J.B.; Tang W.; Synthesis of cyclobutenes by highly selective transition-metal-catalyzed ring expansion of cyclopropanes. Angew Chem Int Ed Engl 2008,47(46),8933-8936","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/1521-3765(20001016)6:20<3706:AID-CHEM3706>3.0.CO;2-P","volume":"6","author":"Huang D.J.","year":"2000","unstructured":"Huang D.J.; Rayabarapu D.K.; Li L.P.; Sambaiah T.; Cheng C.H.; Nickel-catalyzed. Chemistry 2000,6(20),3706-3713","journal-title":"Chemistry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1021\/jo010609y","volume":"66","author":"Chao K.C.","year":"2001","unstructured":"Chao K.C.; Rayabarapu D.K.; Wang C.C.; Cheng C.H.; Cross [2 + 2] cycloaddition of bicyclic alkenes with alkynes mediated by cobalt complexes: a facile synthesis of cyclobutene derivatives. J Org Chem 2001,66(26),8804-8810","journal-title":"J Org Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"10781","DOI":"10.1002\/anie.201605008","volume":"55","author":"Kosobokov M.","year":"2016","unstructured":"Kosobokov M.; Cui B.; Balia A.; Matsuzaki K.; Tokunaga E.; Saito N.; Shibata N.; Importance of a Fluorine Substituent for the Preparation of meta- and para-Pentafluoro-\u03bb(6) -sulfanyl-Substituted Pyridines. Angew Chem Int Ed Engl 2016,55(36),10781-10785","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1016\/S0040-4020(00)00579-2","volume":"56","author":"Miyata O.","year":"2000","unstructured":"Miyata O.; Ozawa Y.; Ninomiya I.; Naito T.; radical cyclization in heterocycle synthesis. Part 10: A Concise Synthesis of (\u2212)-Kainic Acid via Sulfanyl Radical Addition\u2013Cyclization\u2013Elimination Reaction. Tetrahedron 2000,56,6199-6207","journal-title":"Tetrahedron"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1039\/C9QO00191C","volume":"6","author":"Saidalimu I.","year":"2019","unstructured":"Saidalimu I.; Liang Y.; Niina K.; Tanagawa K.; Saito N.; Shibata N.; Synthesis of aryl and heteroaryl tetrafluoro-\u03bb 6-sulfanyl chlorides from diaryl disulfides using trichloroi socyanuric acid and potassium fluoride. Org Chem Front 2019,6,1157-1161","journal-title":"Org Chem Front"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1039\/C8SC01216D","volume":"9","author":"Das P.","year":"2018","unstructured":"Das P.; Niina K.; Hiromura T.; Tokunaga E.; Saito N.; Shibata N.; An eccentric rod-like linear connection of two heterocycles: synthesis of pyridine trans-tetrafluoro-\u03bb6-sulfanyl triazoles. Chem Sci (Camb) 2018,9(22),4931-4936","journal-title":"Chem Sci (Camb)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1021\/ol203446t","volume":"14","author":"Zeng X.","year":"2012","unstructured":"Zeng X.; Ilies L.; Nakamura E.; Iron-catalyzed regio- and stereoselective chlorosulfonylation of terminal alkynes with aromatic sulfonyl chlorides. Org Lett 2012,14(3),954-956","journal-title":"Org Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/adsc.200404146","volume":"346","author":"Reddy D.","year":"2004","unstructured":"Reddy D.; Vogel P.; Palladium\u2010catalyzed desulfitative sonogashira\u2013hagihara cross\u2010couplings of arenesulfonyl chlorides and terminal alkynes. Adv Synth Catal 2004,346,1793-1797","journal-title":"Adv Synth Catal"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13189\/app.2018.060101","volume":"6","author":"Figueroa L.","year":"2018","unstructured":"Figueroa L.; Hau L.; Garc\u00eda E.; L\u00f3pez M.; D\u00edaz F.; Pool E.; Rosas M.; Herrera S.; Mateu V.; cahuich, regina.; ehuan, saidy. evaluation of inotropic activity of fluorobenzene derivative using an isolated rat heart model. Adv Pharmacol Pharm 2018,6,1-11","journal-title":"Adv Pharmacol Pharm"},{"key":"ref=45","first-page":"184","volume":"38","author":"Achhammer I.","year":"1988","unstructured":"Achhammer I.; H\u00e4cker W.; Glocke M.; Efficacy and safety of torasemide in patients with chronic heart failure. Arzneimittelforschung 1988,38(1A),184-187","journal-title":"Arzneimittelforschung"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0014-2999(02)02484-6","volume":"456","author":"Chapman J.G.","year":"2002","unstructured":"Chapman J.G.; Magee W.P.; Stukenbrok H.A.; Beckius G.E.; Milici A.J.; Tracey W.R.; A novel nonpeptidic caspase-3\/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl] isatin reduces myocardial ischemic injury. Eur J Pharmacol 2002,456(1-3),59-68","journal-title":"Eur J Pharmacol"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183596","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183596\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T18:57:38Z","timestamp":1638644258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183596\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207323666200709163008","relation":{},"ISSN":["1386-2073"],"issn-type":[{"type":"print","value":"1386-2073"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}